Genosensors, a nanomaterial-based platform for microRNA-21 detection, non-invasive methods in early detection of cancer
Related Experiment Video
Updated: Oct 2, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
Sepideh Sadighbathi1, Ahmad Mobed2
1Department of Comparative Biomedicine and Nutrition, Università degli Studi di Padova Padova, Italy.
Abstract:
MicroRNAs are small non-coding RNAs that are 18-24 nucleotides in length. Among the most widely studied microRNAs, microRNA21 (miR21) is highly expressed in many mammalian cell types. It regulates numerous biological functions such as differentiation, proliferation, apoptosis, and migration. Therefore, sensitive and specific detection of miR-21 is crucial in medical approaches. Several methods such as ISH, northern blotting, RT-PCR, microarray, and next-generation are conventionally used to detect miR-21. Due to the limitations and problems related to routine methods, the development of advanced and modern methods has been one of the investigation goals of researchers in recent years. Nanotechnology-based methods have been among the most critical methods in the last two decades. Biosensors are one of the primary modern methods that largely overcome the limitations of routine procedures. The present study introduces and discusses routine methods for the detection of miR-21and the related up-to-date biosensors developed in recent years (2019-2021).
More Related Videos
08:12Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016